As the second day of Healthcare Week Luxembourg (HWL) got underway this Wednesday 8 October at Luxexpo The Box, the list of winners of the HWL awards was unveiled at the gala dinner held on Tuesday, for this third edition. MPC Therapeutics, eSklepios, IEE and CHU Liège were selected by the jury from a list of 12 companies, start-ups and institutions, “to reward their achievements in four categories in the healthcare sector: start-up in Europe, start-up in Luxembourg, medical innovation and managerial innovation”, explains the press release.
Launched in 2020 as a spin-off from the University of Geneva, MPC Therapeutics develops innovative small molecules that reprogram mitochondrial function and rejuvenate cells. Its lead product, MitoStemX, “is an ex vivo reagent designed to improve the fitness and persistence of Car-T cells, thereby enhancing their efficacy in the fight against and treatment of cancer”.
Created by two Luxembourg doctors, Fabien Cipriani and Jean-François Michel, eSklepios for its part offers a modular electronic medical records system that optimises workflows and integrates clinical, administrative and regulatory management. It aims to comply with European standards and align with the vision set out in the European Health Data Space (EHDS) regulation.
In the medical innovation category, it was IEE that won, with the development of the Suralis system, which consists of intelligent sensors integrated into shoe soles to restore the sensations of amputees wearing prostheses, thus improving their stability, reducing phantom pain and improving their mobility.
In the managerial innovation category, it was CHU Liège, which has more than 6.400 employees, which convinced the jury, with the development of Baby Detect, an innovative and advanced genomic screening programme for newborns, designed to broaden the range of disorders identifiable at birth and enable immediate intervention and treatment.
